Comparative effectiveness of different treatment pathways for opioid use disorder

SE Wakeman, MR Larochelle, O Ameli… - JAMA network …, 2020 - jamanetwork.com
Importance Although clinical trials demonstrate the superior effectiveness of medication for
opioid use disorder (MOUD) compared with nonpharmacologic treatment, national data on …

Systematic review of HIV treatment adherence research among people who inject drugs in the United States and Canada: evidence to inform pre-exposure …

AR Bazzi, ML Drainoni, DL Biancarelli, JJ Hartman… - BMC public health, 2019 - Springer
Background People who inject drugs (PWID) are at increased risk for HIV acquisition and
could benefit from antiretroviral pre-exposure prophylaxis (PrEP). However, PrEP has been …

The deepening opioid crisis in North America: historical context and current solutions

JH Donroe, ME Socias, BDL Marshall - Current Addiction Reports, 2018 - Springer
Abstract Purpose of Review The purpose of this review is to (1) detail the historical context
behind the rise of opioid use disorder (OUD) and opioid-related harms in the United States …

Perspectives on HIV pre-exposure prophylaxis (PrEP) utilization and related intervention needs among people who inject drugs

KB Biello, AR Bazzi, MJ Mimiaga, DL Biancarelli… - Harm reduction …, 2018 - Springer
Background Antiretroviral pre-exposure prophylaxis (PrEP) is clinically efficacious and
recommended for HIV prevention among people who inject drugs (PWID), but uptake …

Infectious diseases and injection drug use: public health burden and response

A Levitt, J Mermin, CM Jones, I See… - The Journal of …, 2020 - academic.oup.com
Over the past 2 decades, the United States (US) has experienced an unprecedented
increase in overdose deaths as well as infectious disease consequences primarily …

Integrating HIV preexposure prophylaxis with community-based syringe services for women who inject drugs: results from the project SHE demonstration study

AM Roth, NK Tran, M Felsher… - JAIDS Journal of …, 2021 - journals.lww.com
Methods: WWID≥ 18 years were educated about and offered 24 weeks of daily PrEP.
Participants completed surveys and clinical assessments at baseline and at weeks 1, 3, 12 …

Limited knowledge and mixed interest in pre-exposure prophylaxis for HIV prevention among people who inject drugs

AR Bazzi, DL Biancarelli, E Childs… - AIDS patient care and …, 2018 - liebertpub.com
People who inject drugs (PWID) experience sexual and injection-related HIV risks, but
uptake of pre-exposure prophylaxis (PrEP) for HIV prevention among PWID has been low …

Sexual risk behaviors and STDs among persons who inject drugs: a national study

KA Brookmeyer, LT Haderxhanaj, M Hogben… - Preventive …, 2019 - Elsevier
Opioid use and the rising case reports of STDs represent co-occurring epidemics; research
indicates that persons who inject drugs (PWID) may be at increased risk for acquiring STDs …

Low-threshold buprenorphine treatment in a syringe services program: program description and outcomes

A Jakubowski, BL Norton, BT Hayes… - Journal of addiction …, 2022 - journals.lww.com
Objectives: Low-threshold buprenorphine treatment aims to reduce barriers to evidence-
based opioid use disorder treatment. We aimed to describe the treatment philosophy …

The past, present, and future of PrEP implementation among people who use drugs

KB Biello, MJ Mimiaga, PK Valente, N Saxena… - Current HIV/AIDS …, 2021 - Springer
Purpose of review Recent HIV outbreaks among people who use drugs (PWUD) necessitate
additional HIV prevention tools. Pre-exposure prophylaxis (PrEP) is highly efficacious yet …